Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07377487
What this trial is testing

TheraSphere Japan Pre-Market Study

Who this might be right for
Liver Neoplasms
Boston Scientific Corporation 51
Early research (Phase 1)Temporarily pausedNCT00909558
What this trial is testing

Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer

Who this might be right for
Breast CancerGliomaHepatocellular Cancer+4 more
Envita Medical Center, Inc. 24
Not applicableStudy completedNCT05297955
What this trial is testing

Circulating Tumor Cell Detection in Hepatocellular Carcinoma

Who this might be right for
Circulating Tumor Cell
Tongji Hospital 458
Large-scale testing (Phase 3)UnknownNCT05544253
What this trial is testing

Safety and Efficacy of Mitomycin C-based HIPEC After srHCC and PM of HCC

Who this might be right for
Hepatocellular CarcinomaPeritoneal MetastasisHyperthymic+1 more
West China Hospital 68
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07836712
What this trial is testing

Multiple Adjunct Therapies to Improve Immunotherapy Treatment in Patients With Locally Advanced or Metastatic Melanoma or Advanced Hepatocellular Cancer

Who this might be right for
Advanced Hepatocellular CarcinomaAdvanced MelanomaLocally Advanced Melanoma+3 more
University of Southern California 46
Early research (Phase 1)UnknownNCT01266707
What this trial is testing

Antiangiogenic Peptide Vaccine Therapy in Treating Patient With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Fukushima Medical University 9
Not applicableUnknownNCT01892072
What this trial is testing

VEGF Signaling Promotes Cell Growth and Metastasis in Hepatocellular Carcinoma in a VEGF Receptor Mediated Pathway

Who this might be right for
Hepatocellular Carcinoma
First Affiliated Hospital, Sun Yat-Sen University 50
Not applicableActive Not RecruitingNCT04736121
What this trial is testing

Selective Internal Radiation Therapy (SIRT) Using SIR-Spheres® Y-90 Resin Microspheres on DoR & ORR in Unresectable Hepatocellular Carcinoma Patients

Who this might be right for
Unresectable Hepatocellular CarcinomaBCLC Stage A Hepatocellular CarcinomaBCLC Stage B Hepatocellular Carcinoma+1 more
Sirtex Medical 100
Testing effectiveness (Phase 2)Ended earlyNCT03422679
What this trial is testing

Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies

Who this might be right for
Breast CancerColorectal CancerAdenoid Cystic Carcinoma+5 more
Cellestia Biotech AG 79
Testing effectiveness (Phase 2)UnknownNCT02959151
What this trial is testing

Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy

Who this might be right for
Carcinoma, HepatocellularPancreatic Cancer MetastaticColorectal Cancer Metastatic
Shanghai GeneChem Co., Ltd. 20
Early research (Phase 1)Active Not RecruitingNCT03257761
What this trial is testing

Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer

Who this might be right for
Extrahepatic Bile Duct Adenocarcinoma, Biliary TypeGallbladder Adenocarcinoma, Biliary TypeMetastatic Pancreatic Adenocarcinoma+25 more
University of Southern California 55
Testing effectiveness (Phase 2)Study completedNCT00142428
What this trial is testing

Cetuximab in Patients With Unresectable or Metastatic Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Massachusetts General Hospital 30
Very early researchStudy completedNCT02683200
What this trial is testing

MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver Cancer

Who this might be right for
Adult Hepatocellular CarcinomaMetastatic Malignant Neoplasm in the Liver
Jonsson Comprehensive Cancer Center 21
Testing effectiveness (Phase 2)Looking for participantsNCT07179900
What this trial is testing

Radiotherapy Combined With QL1706 and Bevacizumab for Unresectable Non-metastatic Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Hebei Medical University Fourth Hospital 60
Early research (Phase 1)Study completedNCT02143401
What this trial is testing

Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
CirrhosisHepatitis B InfectionHepatitis C Infection+6 more
National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)UnknownNCT05809869
What this trial is testing

Immunotherapy and Radioembolisation for Metastatic Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
The University of Hong Kong 25
Testing effectiveness (Phase 2)Study completedNCT02089633
What this trial is testing

Pegylated Recombinant Human Arginase 1 in Combination With Oxaliplatin and Capecitabine for the Treatment of HCC

Who this might be right for
Hepatocellular Carcinoma
Bio-Cancer Treatment International Limited 17
Testing effectiveness (Phase 2)Study completedNCT02683538
What this trial is testing

Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies

Who this might be right for
Hepatocellular CarcinomaMetastasisCholangiocarcinoma
Seoul National University Hospital 196
Early research (Phase 1)Study completedNCT01183663
What this trial is testing

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 180
Early research (Phase 1)Looking for participantsNCT06915753
What this trial is testing

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

Who this might be right for
Metastatic Hepatocellular CarcinomaSolid TumorsSolid Tumor, Adult+8 more
Tyra Biosciences, Inc 125
Next Page